Hylios
HomeIntelligencePricingResourcesNews
LoginFree daily briefStart a Pilot
Back to Intelligence

#industry-policy

(1 articles)
Risk & Disruption
High ImpactAug 9, 2026

GBMA White Paper: Pharma Supply Chain Reforms for Resilience

The Global Biopharmaceutical Manufacturers Association (GBMA) has published a white paper advocating for structural reforms to enhance supply chain resilience within the pharmaceutical industry. This

PharmaDispatch#supply-chain-resilience#pharmaceutical-logistics#gbma-white-paper

Hylios

Hylios - Better Decisions. Made Faster.

Newsletter

The daily supply chain brief, free. Unsubscribe any time.

Product

  • Features
  • Shipper Network Diagnostic
  • Deal Intelligence
  • Demand Intelligence
  • For Carriers
  • Tariff Exposure
  • Pricing
  • Design Partners
  • Documentation

Guides

  • Digital Twin Guide
  • Simulation Guide
  • Modeling Guide
  • Sandbox Guide
  • Intelligence Buyer's Guide
  • Hylios vs Alternatives
  • Methodology

Company

  • About
  • News
  • Careers

Legal

  • Privacy Policy
  • Terms of Service
© 2026 Hylios. All rights reserved.